Disease | tardive dyskinesia |
Comorbidity | C0036337|schizoaffective disorder |
Sentences | 1 |
PubMedID- 22071797 | Objectives: to determine the effects of calcium-channel blocker drugs (diltiazem, nifedipine, nimodipine, verapamil) for treatment of neuroleptic-induced tardive dyskinesia in people with schizophrenia, schizoaffective disorder or other chronic mental illnesses. |
Page: 1